Entereg User Fee Date Pushed Back To May
Extension allows FDA to review revised RiskMAP recently submitted by Adolor for the postoperative ileus treatment.
Extension allows FDA to review revised RiskMAP recently submitted by Adolor for the postoperative ileus treatment.